Utility of PET/CT in patients with stage I-III melanoma

被引：9
|
作者：
Aviles Izquierdo, J. A. [1 ]
Molina Lopez, I. [1 ]
Sobrini Morillo, P. [2 ]
Marquez Rodas, I. [3 ,4 ]
Mercader Cidoncha, E. [5 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Serv Dermatol, Calle Dr Esquerdo 46, Madrid 28007, Spain
[2] Univ Complutense Madrid, Fac Med, Madrid, Spain
[3] Hosp Gen Univ Gregorio Maranon, Serv Oncol Med, Madrid, Spain
[4] Ciberonc, Madrid, Spain
[5] Hosp Gen Univ Gregorio Maranon, Serv Cirugia Gen, Madrid, Spain
来源：
CLINICAL & TRANSLATIONAL ONCOLOGY | 2020年 / 22卷 / 08期
关键词：
Melanoma; Diagnosis; Staging; PET; CT; Sentinel lymph node biopsy; Complete lymph node dissection; Skin metastases; F-18-FDG PET/CT; TOMOGRAPHY; CT;
D O I：
10.1007/s12094-019-02252-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Purpose To study the utility of positron emission tomography with computerized tomography (PET/CT) in patients with a stage I-III melanoma. Patients and methods PET/CT findings from all patients with a stage I-III melanoma attended at our hospital from September 2011 to November 2015 were reviewed. Results Data from 83 patients with a stage I-III melanoma, 39 patients with a positive sentinel lymph node biopsy (SLNB) and 35 patients with locoregional recurrences were analyzed. Sensitivity of PET/CT in clinical stage I-III patients was 5%, with a 14% of false positives. In patients with a positive SLNB, PET/CT previous to complete lymph node dissection had a 23% of false negatives. In patients with clinical locoregional recurrences, PET/CT findings revealed asymptomatic visceral distant metastasis in 25.7%. Conclusions PET/CT has a significant rate of false positive and negative results in patients with a stage I-III melanoma. Utility in patients with nodal locoregional recurrences seems higher than in patients with skin metastases.
引用
收藏
页码：1414 / 1417
页数：4
相关论文
共 50 条
  • [31] Communication in decision aids for stage I-III colorectal cancer patients: a systematic review
    Hommes, Saar
    Vromans, Ruben
    Clouth, Felix
    Verbeek, Xander
    de Hingh, Ignace
    Krahmer, Emiel
    BMJ OPEN, 2021, 11 (04):
  • [32] UNDERSTANDING REASONS FOR LACK OF SURGICAL TREATMENT IN PATIENTS WITH STAGE I-III GASTRIC CANCER
    Ward, Jessica
    Chuy, Jennifer
    Friedmann, Patricia
    In, Haejin
    GASTROENTEROLOGY, 2020, 158 (06) : S1553 - S1553
  • [33] A Cohort Study of Metformin Exposure and Survival in Patients with Stage I-III Colorectal Cancer
    Spillane, Susan
    Bennett, Kathleen
    Sharp, Linda
    Barron, Thomas I.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (08) : 1364 - 1373
  • [34] False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma
    Amanda A. G. Nijhuis
    Mbathio Dieng
    Nikita Khanna
    Sally J. Lord
    Jo Dalton
    Alexander M. Menzies
    Robin M. Turner
    Jay Allen
    Robyn P. M. Saw
    Omgo E. Nieweg
    John F. Thompson
    Rachael L. Morton
    Annals of Surgical Oncology, 2019, 26 : 1860 - 1868
  • [35] Disseminated Tumor Cells in Biologic Subtypes of Stage I-III Breast Cancer Patients
    Hall, Carolyn
    Krishnamurthy, Savitri
    Lodhi, Ashutosh
    Mosalpuria, Kailash
    Kuerer, Henry M.
    Meric-Bernstam, Funda
    Bedrosian, Isabelle
    Hunt, Kelly K.
    Lucci, Anthony
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (12) : 3252 - 3258
  • [36] Adjuvant docetaxel and carboplatin chemotherapy for patients with FIGO stage I-III endometrial cancer
    Kudaka, W.
    Nakasone, T.
    Arakaki, Y.
    Nakamoto, T.
    Wakayama, A.
    Kinjyo, Y.
    Taira, Y.
    Nagai, Y.
    Kaneshima, I.
    Nishihira, K.
    Aoki, Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 1011 - 1011
  • [37] INDEPENDENT FACTORS FOR POOR PROGNOSIS IN YOUNG PATIENTS WITH STAGE I-III BREAST CANCER
    Eric, Ivan
    Eric, Anamarija Petek
    Koprivcic, Ivan
    Babic, Marko
    Pacaric, Stana
    Trogrlic, Bojan
    ACTA CLINICA CROATICA, 2020, 59 (02) : 242 - 251
  • [38] False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma
    Nijhuis, Amanda A. G.
    Dieng, Mbathio
    Khanna, Nikita
    Lord, Sally J.
    Dalton, Jo
    Menzies, Alexander M.
    Turner, Robin M.
    Allen, Jay
    Saw, Robyn P. M.
    Nieweg, Omgo E.
    Thompson, John F.
    Morton, Rachael L.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (06) : 1860 - 1868
  • [39] The Frequency and Determinants of Metabolic Syndrome in Operated Patients with Stage I-III Breast Cancer
    Sarici, Furkan
    Sunar, Veli
    Aksoy, Sercan
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2020, 30 (01): : 1 - 10
  • [40] Prognostic value of a modified Immunoscore in patients with stage I-III resectable colon cancer
    Zhao, Ke
    Wu, Xiaomei
    Li, Zhenhui
    Wang, Yingyi
    Xu, Zeyan
    Li, Yajun
    Wu, Lin
    Yao, Su
    Huang, Yanqi
    Liang, Changhong
    Liu, Zaiyi
    CHINESE JOURNAL OF CANCER RESEARCH, 2021, 33 (03) : 379 - +
12345